Coagulant Therapeutics
Manufacturing · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
2630 Bancroft Way, Berkeley, California,...Revenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Coagulant Therapeutics
Coagulant Therapeutics is focused on developing innovative medicines to address acute bleeding, an unmet medical need associated with conditions such as postpartum hemorrhage and traumatic brain injury. The company leverages over 100 years of collective expertise in the coagulation cascade and biologics, along with a portfolio of over 30 patents, to create optimized hemostatic agents. Their lead product, CT-001, is an engineered Factor VIIa designed to enhance efficacy and safety for patients experiencing acute bleeding. The intended clients include healthcare providers and patients affected by various forms of acute bleeding.Explore more
Coagulant Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Coagulant Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Coagulant Therapeutics is spiking on competitors!
Coagulant Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Coagulant Therapeutics
Funding: Get notified immidiatlly once Coagulant Therapeutics has new funding data
Click to see if Coagulant Therapeutics had a recent Job posting/layoffs
Check if Coagulant Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Coagulant Therapeutics recently announced quarterly report
Product Launch: Get notified when Coagulant Therapeutics launches new products
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Coagulant Therapeutics
Compare insights from companies similar to Coagulant Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
<$5M
1-10
Private
<$5M
2019
Company Profile Activity
Activity Insights
Coagulant Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Coagulant Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Coagulant Therapeutics.
Coagulant Therapeutics Tech Stack
A closer look at the technologies used by Coagulant Therapeutics
Coagulant Therapeutics News & Media
Coagulant Therapeutics Announces Publication of In Vivo Data Demonstrating Safety and Efficacy of CT-001 for the Management of Acute Bleeding
The short duration of enhanced FVIIa procoagulant activity provided by CT-001 has the potential to be an optimal paradigm for the treatment of acute bleeds CT-001 to be evaluated as a treatment for severe postpartum hemorrhage SAN FRANCISCO, July 7, 2022 /PRNewswire/ -- Coagulant...
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Coagulant Therapeutics
Sign Up For FreeTo access detailed company insights
Coagulant Therapeutics is focused on developing innovative medicines to address acute bleeding, an unmet medical need associated with conditions such as postpartum hemorrhage and traumatic brain injury. The company leverages over 100 years of collective expertise in the coagulation cascade and biologics, along with a portfolio of over 30 patents, t... Read More
